Articles in Scholarly Journals [Incomplete List]

1. Autocrine S100B effects on astrocytes are mediated via RAGE
   Journal of Neuroimmunology, vol. 184, no. 1-2, pp. 214–222, 2007
2. Cognitive impairment and in vivo metabolites in first-episode neuroleptic-naive and chronic medicated schizophrenic patients: A proton magnetic resonance spectroscopy study
   Journal of Psychiatric Research, vol. 41, no. 8, pp. 625–634, 2007
3. Glial cell activation in a subgroup of patients with schizophrenia indicated by increased S100B serum concentrations and elevated myo-inositol
   Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol. 31, no. 2, pp. 361–364, 2007
4. Different activation patterns of proinflammatory cytokines in melancholic and non-melancholic major depression are associated with HPA axis activity
   Journal of Affective Disorders, vol. 87, no. 2-3, pp. 305–311, 2005
5. Psychische Erkrankungen und Immunsystem
   PPmP - Psychotherapie · Psychosomatik · Medizinische Psychologie, vol. 55, no. 1, pp. 36–48, 2005
6. Basal Prolactin Values Correlate with Response to Reboxetine Treatment in Major Depression, but Not with Response to Citalopram
   Neuropsychobiology, vol. 51, no. 2, pp. 67–71, 2005
7. Search for atypical lymphocytes in schizophrenia
   The World Journal of Biological Psychiatry, vol. 5, no. 1, pp. 33–37, 2004
8. Glial cell dysfunction in schizophrenia indicated by increased S100B in the CSF
   Molecular Psychiatry, vol. 9, no. 10, Article ID 4001548, 2 pages, 2004
9. S100B Serum Levels and Long-Term Improvement of Negative Symptoms in Patients with Schizophrenia
   Neuropsychopharmacology, vol. 29, no. 5, Article ID 1300403, 7 pages, 2004
10. The Impact of the Selective Monoamine Reuptake Inhibitors Reboxetine and Citalopram on Visually-Evoked Event-Related Potentials in Depressed Patients
    Pharmacopsychiatry, vol. 37, no. 5, pp. 200–205, 2004
11. The astroglial protein S100B and visually evoked event-related potentials before and after antidepressant treatment
    Psychopharmacology, vol. 178, no. 2-3, pp. 161–166, 2004
12. Target evaluation processing and serum levels of nerve tissue protein S100B in patients with remitted major depression
    Neuroscience Letters, vol. 354, no. 1, pp. 69–73, 2004
13. S100B potently activates p65/c-Rel transcriptional complexes in hippocampal neurons: Clinical implications for the role of S100B in excitotoxic brain injury
    Neuroscience, vol. 127, no. 4, pp. 913–920, 2004
14. Oral citalopram and reboxetine challenge tests before and after selective antidepressant treatment
    Journal of Psychiatric Research, vol. 37, no. 3, pp. 261–262, 2003
15. S100B in brain damage and neurodegeneration
    Microscopy Research and Technique, vol. 60, no. 6, pp. 614–632, 2003
16. S100B and response to treatment in major depression: a pilot study
    European Neuropsychopharmacology, vol. 13, no. 4, pp. 235–239, 2003
17. Immunological research in clinical psychiatry: report on the consensus debate during the 7th expert meeting on psychiatry and immunology
    Molecular Psychiatry, vol. 7, no. 8, pp. 822–826, 2002
18. Vascular Endothelial Growth Factor Protects Cultured Rat Hippocampal Neurons Against Hypoxic Injury via an Antiexcitotoxic, Caspase-Independent Mechanism
    Journal of Cerebral Blood Flow & Metabolism, pp. 1170–1175, 2002
19. The Influence of Typical and Atypical Neuroleptic Drugs in the Production of Interleukin-2 and Interferon-Gamma in vitro
    Neuropsychobiology, vol. 46, no. 4, pp. 180–185, 2002
20. Increased S100B blood levels in unmedicated and treated schizophrenic patients are correlated with negative symptomatology
    Molecular Psychiatry, vol. 6, no. 4, Article ID 4000889, 4 pages, 2001
21. Inflammatory markers in major depression and melancholia
    Journal of Affective Disorders, vol. 63, no. 1-3, pp. 93–102, 2001
22. S-100B is increased in melancholic but not in non-melancholic major depression
    Journal of Affective Disorders, vol. 66, no. 1, pp. 89–93, 2001
23. Review of Immunological and Immunopathological Findings in Schizophrenia
    Brain, Behavior, and Immunity, vol. 15, no. 4, pp. 319–339, 2001
24. Traumatische Trauer - ein eigenständiges Krankheitsbild?
    Psychotherapeut, vol. 46, no. 5, pp. 301–308, 2001
25. Different immune patterns in melancholic and non-melancholic major depression
    European Archives of Psychiatry and Clinical Neuroscience, vol. 251, no. 2, pp. 90–97, 2001
26. Elevated plasma levels of S-100b protein in schizophrenic patients
    Biological Psychiatry, vol. 45, no. 11, pp. 1508–1511, 1999
27. Effects of amantadine treatment on in vitro production of interleukin-2 in de-novo patients with idiopathic Parkinson's disease
    Journal of Neuroimmunology, vol. 98, no. 2, pp. 214–220, 1999
28. Increased serum neopterin levels in acutely ill and recovered schizophrenic patients
    Schizophrenia Research, vol. 32, no. 1, pp. 63–67, 1998
29. Immunological Dysfunction in Schizophrenia: A Systematic Approach
    Neuropsychobiology, vol. 37, no. 4, pp. 186–193, 1998
30. Production of interferon-gamma in families with multiple occurrence of schizophrenia
    Psychiatry Research, vol. 66, no. 2-3, pp. 145–152, 1997
31. Deutsche und amerikanische Konsiliarpsychiater beurteilen ihre Tätigkeit
    Der Nervenarzt, vol. 68, no. 9, pp. 735–741, 1997
32. Investigations of cytokine production in whole blood cultures of paranoid and residual schizophrenic patients
    European Archives of Psychiatry and Clinical Neuroscience, vol. 246, no. 5, pp. 279–284, 1996
33. Production of cytokines in acute schizophrenic psychosis
    Biological Psychiatry, vol. 40, no. 12, pp. 1294–1297, 1996